Gefitinib plus crizotinib treatment and rechallenge for EGFR-mutated... | Download Scientific Diagram
The pathogenesis of MET amplification and MET exon 14 alterations.... | Download Scientific Diagram
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
Cancers | Free Full-Text | MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities
The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance fr
JPM | Free Full-Text | MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
The role of MET in chemotherapy resistance | Oncogene
What Is MET? - MET Crusaders
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors | Experimental Hematology & Oncology | Full Text
Cancers | Free Full-Text | An Observatory for the MET Oncogene: A Guide for Targeted Therapies
Beyond epidermal growth factor receptor: MET amplification as a general resistance driver to targeted therapy in oncogene-driven non-small-cell lung cancer - ScienceDirect
Frontiers | Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
Key Points about MET in Lung Cancer - YouTube
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Cancers | Free Full-Text | Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - ScienceDirect
![PDF] Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9da09096698590ee3eb74818d1723d8c911a454e/3-Figure1-1.png "PDF] Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment | Semantic Scholar")
PDF] Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment | Semantic Scholar
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer | Journal of Cancer Research and Clinical Oncology
Targeted Therapies Expanding for MET Dysregulation in NSCLC - ILCN.org (ILCN/WCLC)
Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer | Biomarker Research | Full Text
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregula | OTT
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
奥希替尼在非小细胞肺癌靶向治疗中的获得性耐药机制| Semantic Scholar
Frontiers | Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation
